KURA
Kura Oncology, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.0% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +3 | 46.85M | $513.57M | +7 | −4 |
| Q1 2026 | 85 | 0 | 43.54M | $354.05M | +5 | −5 |
| Q4 2025 | 85 | 0 | 47.00M | $488.20M | +1 | −1 |
| Q3 2025 | 15 | -1 | 31.70M | $280.57M | — | −1 |
| Q2 2025 | 13 | 0 | 25.43M | $146.75M | — | — |
| Q1 2025 | 10 | 0 | 9.58M | $63.25M | — | — |
| Q4 2024 | 10 | -1 | 11.52M | $100.37M | +1 | −2 |
| Q3 2024 | 10 | 0 | 4.92M | $96.24M | +1 | −1 |
| Q2 2024 | 10 | — | 4.04M | $83.12M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 9.47M | — | $54.64M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 5.35M | — | $30.86M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 5.35M | — | $30.86M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 5.35M | — | $30.86M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 5.35M | — | $30.86M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 5.35M | — | $30.86M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 3.04M | -7.5% | $17.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Millennium Management ✦ | 2.62M | +44.9% | $15.13M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passief) | 2.01M | +11.7% | $11.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passief) | 2.01M | +11.7% | $11.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 1.06M | +98.5% | $6.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 941.67K | +23.9% | $5.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 941.67K | +23.9% | $5.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 941.67K | +23.9% | $5.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 941.67K | +23.9% | $5.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 941.67K | +23.9% | $5.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 364.15K | -7.6% | $2.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 310.24K | +95.1% | $1.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 140.71K | -66.4% | $811,914 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 140.71K | -66.4% | $811,914 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 45.20K | — | $260,812 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 45.20K | — | $260,812 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Marshall Wace ✦ | 42.36K | -89.2% | $244,434 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 37 | Marshall Wace ✦ | 42.36K | -89.2% | $244,434 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 39.57K | +24.8% | $229,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 217 houders, 84.35M aandelen, $677.88M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · President and CEO · 100.00K aand @ 12.39 · $1.24M
Officer, Director · President and CEO · 100.00K aand @ 11.12 · $1.11M
Open-market verkopen (S)
Officer · 4.34K aand · $51,663
Officer · 31.49K aand · $397,681
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie